Kytopen on September 23, 2022

Kytopen to present at the Alliance for Regenerative Medicine's 2022 Cell & Gene Meeting on the Mesa

Our CTO, Bethany Grant, Ph.D., will discuss how the Flowfect® platform can unlock the healing power of cells. Our revolutionary platform enables high-throughput, continuous-flow transfection from discovery to production. Come learn about the most recent advances with the Flowfect® platform. Together we can help lead a change in the current state of immunotherapy production and enable access to state-of-the-art cell therapy-based care.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,700 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.